Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
107,573,681
Number of holders
24
Total 13F shares, excl. options
21,008,583
Shares change
+2,323,041
Total reported value, excl. options
$11,976,111
Value change
+$1,320,422
Number of buys
11
Number of sells
-11
Price
$0.5701

Significant Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q1 2025

31 filings reported holding VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share as of Q1 2025.
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 21,008,583 shares of 107,573,681 outstanding shares and own 20% of the company stock.
Largest 10 shareholders include Lagoda Investment Management, L.P. (10,194,000 shares), ARMISTICE CAPITAL, LLC (8,206,430 shares), GEODE CAPITAL MANAGEMENT, LLC (761,951 shares), VANGUARD GROUP INC (706,060 shares), BlackRock, Inc. (445,187 shares), STATE STREET CORP (147,638 shares), Silverberg Bernstein Capital Management LLC (140,573 shares), NORTHERN TRUST CORP (117,875 shares), UBS Group AG (83,178 shares), and Squarepoint Ops LLC (60,809 shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.